871640238	871640238	CD	B-NP	O
|	|	NNP	I-NP	O
WMC	WMC	NNP	I-NP	O
|	|	VBD	B-VP	O
64322666	64322666	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8763426	8763426	CD	B-NP	O
|	|	CC	I-NP	O
8/20/2003	8/20/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
Report	Report	NNP	B-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/21/2003	6/21/2003	CD	B-NP	O
Date	Date	NNP	I-NP	O
of	of	IN	B-PP	O
Discharge	Discharge	NNP	B-NP	O
:	:	:	O	O
6/21/2003	6/21/2003	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
NOE	NOE	NNP	B-NP	O
DEMETRIUS	DEMETRIUS	NNP	I-NP	O
MANDELLA	MANDELLA	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diverticulitis	Diverticulitis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NNP	B-NP	O
Mellitus	Mellitus	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
62-year-old	62-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
8/10/2003	8/10/2003	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
approximately	approximately	RB	B-NP	O
6	6	CD	I-NP	O
p.m.	p.m.	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
suddenly	suddenly	RB	B-ADVP	O
became	become	VBD	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
then	then	RB	B-ADVP	O
sat	sit	VBD	B-VP	O
down	down	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
wheelchair	wheelchair	NN	I-NP	O
and	and	CC	O	O
``	``	``	O	O
passed	pass	VBN	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O
''	''	''	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
actually	actually	RB	B-ADVP	O
lost	lose	VBD	B-VP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
back	back	NN	I-NP	O
while	while	IN	B-SBAR	O
EMTs	EMT	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
and	and	CC	O	O
also	also	RB	B-VP	O
complained	complain	VBD	I-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tug	tug	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
unrelieved	unrelieved	JJ	B-ADJP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
;	;	:	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
constant	constant	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
arrival	arrival	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
O2	O2	NN	I-NP	O
sat	sat	NN	I-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
sublingual	sublingual	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
tried	try	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Reported	Report	VBN	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
anterolateral	anterolateral	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

High	High	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
22	22	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-NP	O
26	26	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	I-NP	O
Zoloft	Zoloft	NNP	I-NP	O
50	50	CD	I-NP	O
q.d.	q.d.	NNP	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
100	100	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Penicillin	Penicillin	NNP	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
was	be	VBD	B-VP	O
97	97	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
was	be	VBD	B-VP	O
54-60	54-60	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
100-120/50	100-120/50	CD	B-NP	O
-80	-80	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sat	sat	NN	I-NP	O
was	be	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
6	6	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
moderately	moderately	RB	I-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lung	lung	NN	I-NP	O
are	be	VBP	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
and	and	CC	I-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
38	38	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
D-dimer	D-dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
736	736	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
voltages	voltage	NNS	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
62-year-old	62-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Diagnosis	Diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
new	new	JJ	B-NP	O
O2	O2	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
several	several	JJ	B-NP	O
workups	workup	NNS	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
during	during	IN	B-PP	O
prior	prior	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
systems	system	NNS	I-NP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
therefore	therefore	RB	I-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
By	By	IN	B-PP	O
system	system	NN	B-NP	O
:	:	:	O	O
CARDIAC	CARDIAC	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
3	3	CD	B-NP	O
tests	test	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
returned	return	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
EKG	EKG	NNP	B-NP	O
checked	check	VBD	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
and/or	and/or	CC	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Zocor	Zocor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atenolol	atenolol	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
her	her	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
was	be	VBD	B-VP	O
temporarily	temporarily	RB	B-NP	O
DC	DC	NN	I-NP	B-cell_type
'd	'd	MD	B-VP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
trace-to-mild	trace-to-mild	JJ	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
estimated	estimate	VBN	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
70	70	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
Lasix	Lasix	NNP	I-NP	O
regimen	regimen	NN	I-NP	O
until	until	IN	B-PP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
point	point	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	B-NP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmias	arrhythmia	NNS	B-NP	O
monitored	monitor	VBN	B-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
10/10/2003	10/10/2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
diarrhea	diarrhea	NN	B-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
nonradiating	nonradiate	VBG	I-VP	O
,	,	,	O	O
alternating	alternate	VBG	B-VP	O
sharp	sharp	JJ	B-ADJP	O
and	and	CC	O	O
dull	dull	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
constant	constant	JJ	I-ADJP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
frequent	frequent	JJ	B-NP	O
stools	stool	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
stools	stool	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
bright	bright	JJ	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
as	as	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
versus	versus	CC	O	O
ischemic	ischemic	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
further	further	RB	I-VP	O
evaluate	evaluate	VB	I-VP	O
this	this	DT	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
thickened	thicken	VBN	I-NP	O
colon	colon	NN	I-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
cm	cm	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	B-DNA
flexure	flexure	NN	I-NP	I-DNA
.	.	.	O	O

Given	Give	VBN	B-VP	O
this	this	DT	B-NP	O
information	information	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
GI	GI	NNP	I-NP	O
consult	consult	NN	I-NP	O
's	's	POS	B-NP	O
opinion	opinion	NN	I-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
it	it	PRP	B-NP	O
aggressively	aggressively	RB	B-ADVP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
once	once	RB	O	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
several	several	JJ	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
then	then	RB	B-ADVP	O
,	,	,	O	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
later	later	RB	B-ADVP	O
,	,	,	O	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
Ceptaz	Ceptaz	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
completely	completely	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
needs	need	VBZ	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
having	have	VBG	I-VP	O
any	any	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
difficulties	difficulty	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
included	include	VBD	B-VP	O
chronic	chronic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
versus	versus	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
versus	versus	IN	B-PP	O
deconditioning	deconditione	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
establish	establish	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
Doppler	Doppler	NNP	I-NP	O
exams	exam	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PT	PT	NN	I-NP	B-protein
protocol	protocol	NN	I-NP	I-protein
CT	CT	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
clots	clot	NNS	B-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
cardiopulmonary	cardiopulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
as	as	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
thrombosis	thrombosis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vasculature	vasculature	NN	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
O2	O2	NN	B-NP	B-protein
.	.	.	O	O

RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
at	at	IN	B-PP	O
1.4	1.4	CD	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
that	that	IN	B-ADVP	O
her	her	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
severe	severe	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
fell	fall	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.4	2.4	CD	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
thought	thought	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
represented	represent	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
losses	loss	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pheno	pheno	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
0.71	0.71	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
IV	IV	CD	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
most	most	RBS	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-PP	O
Foley	Foley	NNP	B-NP	O
trauma	trauma	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
in	in	IN	B-PP	O
GI	GI	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
hypertensive	hypertensive	JJ	B-ADJP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
change	change	VB	I-VP	O
her	her	PRP$	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
,	,	,	O	O
Ceptaz	Ceptaz	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
vancomycin	vancomycin	NN	B-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
dramatically	dramatically	RB	B-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
on	on	IN	B-PP	O
9/18	9/18	CD	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
p.o.	p.o.	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
anticipate	anticipate	VBP	B-VP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
2/19/2003	2/19/2003	CD	B-NP	O
.	.	.	O	O

RHEUMATOLOGY	RHEUMATOLOGY	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
10/27/2003	10/27/2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
knee	knee	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
focal	focal	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
patellar	patellar	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
knee	knee	NN	I-NP	O
aspirate	aspirate	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
urate	urate	NN	B-NP	O
crystals	crystal	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
her	her	PRP$	B-NP	O
gout	gout	NN	I-NP	O
flare	flare	NN	I-NP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

ENDOCRINE	ENDOCRINE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
takes	take	VBZ	B-VP	O
70/30	70/30	CD	B-NP	O
insulin	insulin	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
started	start	VBD	B-VP	O
to	to	TO	I-VP	O
begin	begin	VB	I-VP	O
having	have	VBG	I-VP	O
massive	massive	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	B-protein
long-acting	long-acting	JJ	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
,	,	,	O	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
anything	anything	NN	B-NP	O
by	by	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
tolerating	tolerate	VBG	I-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
were	be	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
resumes	resume	VBZ	B-VP	O
one-half	one-half	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
are	be	VBP	B-VP	O
appropriate	appropriate	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
resume	resume	VB	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
dosage	dosage	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
-	-	HYPH	O	O
which	which	WDT	B-NP	O
involves	involve	VBZ	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
on	on	IN	B-PP	O
8/14	8/14	CD	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
on	on	IN	B-PP	O
10/27	10/27	CD	B-NP	O
,	,	,	I-NP	O
1/24	1/24	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
3/1	3/1	CD	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
stop	stop	VB	I-VP	O
,	,	,	O	O
Flagyl	Flagyl	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
11	11	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-NP	O
13	13	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
-	-	HYPH	O	O
once	once	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
dosage	dosage	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
doubled	double	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regular	regular	JJ	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Flexeril	Flexeril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hargus	Hargus	NNP	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
Antibiotics	Antibiotic	NNS	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
2/19/2003	2/19/2003	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
2	2	CD	B-NP	O
.	.	.	O	O

Once	Once	RB	B-ADVP	O
off	off	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Fingerstick	Fingerstick	JJ	B-NP	O
blood	blood	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
regularly	regularly	RB	B-ADVP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
is	be	VBZ	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-2417824	4-2417824	CD	B-NP	O
KFFocus	KFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
OKRENT	OKRENT	NNP	B-NP	O
,	,	,	O	O
REED	REED	NNP	B-NP	O
BOOKER	BOOKER	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PEGELOW	PEGELOW	NNP	B-NP	O
,	,	,	O	O
LINCOLN	LINCOLN	NNP	B-NP	O
ALLEN	ALLEN	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3363726	3363726	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/1/03	1/1/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1/03	1/1/03	CD	B-NP	O

